Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade

Mingo M H Yung, Fiona A. Ross, D. Grahame Hardie, Thomas H Y Leung, Jinbiao Zhan, Hextan Y S Ngan, David W. Chan (Lead / Corresponding author)

Research output: Contribution to journalArticle

14 Citations (Scopus)
202 Downloads (Pure)

Fingerprint Dive into the research topics of 'Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade'. Together they form a unique fingerprint.

Medicine & Life Sciences